• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthBrainstorm Health

Brainstorm Health: Brexit Stockpile, Novartis Cell Therapy, San Francisco Soda Health Warnings

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
February 1, 2019, 5:26 PM ET

Happy Friday, readers!

Elections – and referenda – have consequences. And the UK may soon be grappling with some dire ones for public health if lawmakers are unable to reach a deal on Brexit.

The specter of a so-called “hard Brexit” has already raised fears about intense disruptions to food and drug supply chains, leading some to even stockpile medications, as Reuters reports.

The vast majority of drugs available via the UK’s National Health Service (NHS) come from the EU. Shortly after the decision to leave the European Union, the European Medicines Agency (EMA) – essentially Europe’s version of the Food and Drug Administration – decided to relocate from London to Amsterdam.

With Brexit less than two months away, the pressure is on for the country’s health agencies to make sure ample supplies of life-saving medicines are available for at least a few months. But worried patients have reportedly begun stockpiling treatments themselves. That, itself, presents another wrinkle, as public health officials noted that hoarding up drugs could exacerbate shortages for other patients.

Read on for the day’s news, and have a wonderful weekend.

Sy Mukherjee
@the_sy_guy
[email protected]

DIGITAL HEALTH

Novartis' pioneering cell therapy finally gets a broader UK nod. After facing an initial rejection by NICE, the UK's drug watchdog, over cost concerns, Novartis' Kymriah - the first-ever CAR-T treatment for cancer, which re-engineers patients' own immune cells to fight cancerous cells - has received a green light from the agency to treat certain adult patients with forms of lymphoma. Kymriah had already received clearance in the country for certain pediatric and young adult patients. (PharmaTimes)

THE BIG PICTURE

Big Soda gets a win over San Francisco in court. The beverage industry notched a legal victory over San Francisco public health advocates championed an ordinance requiring health warnings on sugary beverages. The Ninth Circuit Court of Appeals this week ruled that the ordinance violated the 1st Amendment. The ordinance would have required the beverages to carry labeling reading, "WARNING: Drinking beverages with added sugar(s) contributes to obesity, diabetes, and tooth decay." (Coins2Day)

REQUIRED READING

Looking to Change Careers? The Cannabis Industry Wants You, by Anne Fisher

Elon Musk Wants to Build a New Particle Collider for CERN, by Hallie Detrick

Corporations Are Investing in Wind and Solar Energy Now More Than Ever, by Renae Reints

How the Government Shutdown Did (and Didn't) Affect U.S. Employment, by Katia Dmitrieva and Bloomberg

Produced by Sy Mukherjee
@the_sy_guy
[email protected]

Find past coverage. Sign up for other  Coins2Day  newsletters.
About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Most Popular

placeholder alt text
Economy
An unusual Fed ‘rate check’ triggered a free fall in the U.S. dollar and investors are fleeing into gold
By Jim EdwardsJanuary 26, 2026
21 hours ago
placeholder alt text
Success
Despite running $75 billion automaker General Motors, CEO Mary Barra still responds to ‘every single letter’ she gets by hand
By Preston ForeJanuary 26, 2026
16 hours ago
placeholder alt text
Success
'The Bermuda Triangle of Talent': 27-year-old Oxford grad turned down McKinsey and Morgan Stanley to find out why Gen Z’s smartest keep selling out
By Eva RoytburgJanuary 25, 2026
2 days ago
placeholder alt text
North America
Gates Foundation plans to give away $9 billion in 2026 to prepare for the 2045 closure while slashing hundreds of jobs
By Sydney LakeJanuary 23, 2026
4 days ago
placeholder alt text
Personal Finance
Sweden abolished its wealth tax 20 years ago. Then it became a 'paradise for the super-rich'
By Miranda Sheild Johansson and The ConversationJanuary 22, 2026
5 days ago
placeholder alt text
Commentary
Yes, you're getting a bigger tax refund. Your kids won't thank you for the $3 trillion it's adding to the deficit
By Daniel BunnJanuary 26, 2026
19 hours ago

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Latest in Health

Palantir CEO Alex Karp during an interview at the 2026 World Economic Forum in Davos, Switzerland.
InnovationImmigration
Palantir/ICE connections draw fire as questions raised about tool tracking Medicaid data to find people to arrest
By Tristan BoveJanuary 26, 2026
13 hours ago
MagazineLuxury
The $20,000 longevity weekend for those who recognize that more time is the ultimate luxury
By Jaclyn TropJanuary 25, 2026
2 days ago
Secretary of Health and Human Services Robert F. Kennedy Jr. stands at a podium beside a board that depicts an upside-down food pyramid.
HealthFood and drink
Robert F. Kennedy Jr. is redefining the ‘healthy’ American diet—and food companies are making 5 major changes to keep up
By Jake AngeloJanuary 25, 2026
2 days ago
Healthoutdoor and sporting goods
The Best Infrared Saunas of 2026: Tested by Our Team
By Christina SnyderJanuary 23, 2026
4 days ago
trump
North AmericaWHO
After 78 years as a founding member, U.S. fully withdraws from WHO—and it owes over $130 million to the UN agency
By Mike Stobbe, Devi Shastri and The Associated PressJanuary 23, 2026
4 days ago
HealthDietary Supplements
5 Best Massage Guns of 2026: Personally Tested
By Christina SnyderJanuary 22, 2026
4 days ago